Filter posts

IP Sessions at BIO 2015: The Impact of the Inter Partes Review on (BIO)Pharma

The Intellectual Property Track at the BIO International Convention was a chance for IP thought …

BIO Chair Testifies Before Senate

BIO’s Chair and CEO of GlycoMimetics, Rachel King, testified before the Senate Committee on Small …

BIO and University Organizations offer Support of STRONG Patents Act

On March 4, 2015, Senator Chris Coons (D-DE) introduced a new bill, The STRONG Patents …

BIO IPCC Spring Conference Program Announced

BIO’s 2015 IP Counsels Committee Spring Conference & Meeting will be held April 15-17 in …

BIO Deputy General Counsel Remarks on Revised Eligibility Guidance

Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property recently spoke at the U.S. Patent …

USPTO Issues New Myriad Guidance

On Tuesday, December 16 the United States Patent and Trademark Office issued a revised guidance …

Patently Biotech’s Top Articles of 2014

It’s been a whirlwind year for IP. From international trade negotiations, to revised PTO guidelines …

BIO Coalition Submits Patent Reform Letter to Congress

BIO, alongside a coalition of patent holders and inventors, submitted a letter to the chairmen …

New Report Emphasizes the Role of Patent Protection in the Global Diffusion of New Drugs

A new report from the National Bureau of Economic Research (NBER) has determined that strong …

BIO Submits Joint Supplemental Comments on the USPTO March Guidance

Last week BIO, alongside a number of member companies and private individuals, submitted supplemental comments …